Outcome 1: MMSE | Outcome 2: IADL | Outcome 3: NPI | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
r (95% CI) | Standardized r | p value | R 2 | r (95% CI)c | Standardized r | p value | R 2 | r (95% CI)d | Standardized r | p value | R 2 | |
ACB | –0.23 (–0.40 to –0.07) | –0.12 | 0.005 | 28% | 0.42 (–0.71 to 1.55) | 0.04 | 0.47 | 5% | ||||
ADS | –0.37 (–0.57 to –0.16) | –0.12 | 0.005 | 28% | ||||||||
ARS | –0.39 (–0.68 to –0.10) | –0.11 | 0.009 | 27% | ||||||||
Chew’s score | –0.25 (–0.39 to –0.11) | –0.13 | 0.003 | 28% | ||||||||
Han’s score | –0.74 (–1.36 to –0.12)a | –0.09 | 0.02 | 14% | –0.25 (–0.47 to –0.03) | –0.09 | 0.03 | 27% | 1.03 (–0.47 to 2.52) | 0.07 | 0.18 | 5% |
Number of drugs with AC properties | –0.67 (–1.03 to –0.32)b | –0.18 | <0.001 | 16% | –0.27 (–0.39 to –0.16) | –0.20 | <0.001 | 30% | 0.67 (–0.12 to 1.46) | 0.09 | 0.10 | 6% |